logo
episode-header-image
Oct 2024
35m 34s

Newly FDA Approved Alzheimer’s Biomarker...

AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
About this episode
The diagnostic paradigm for Alzheimer's disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for cognitive decline. This podcast is designed to help pathologists and laboratory professionals gain an understanding ... Show More
Up next
Jun 15
Rethinking Cervical Cancer Screening in a Changing Diagnostic Landscape
In this episode of Inside the Lab, Patricia Delgado and Liz Etkin-Kramer explore the evolving landscape of cervical cancer screening amid recent guideline updates emphasizing primary HPV testing, self-collection, and revised screening exit criteria. The conversation examines the ... Show More
54m 53s
Apr 10
Annual Meeting Special Episode – Workforce and Recruitment in Pathology
Recorded live at the 2025 ASCP Annual Meeting in Atlanta, this special episode of Inside the Lab brings together a diverse panel—a practicing pathologist, two medical students, and a resident—to explore one of the profession’s most urgent challenges: the pathology workforce short ... Show More
43m 40s
Feb 2026
Green Labs
In this episode of Inside the Lab, host David Ritter kicks off a new series on corporate responsibility with a timely conversation about Green Labs. Joined by Dr. Ilyssa Gordon and Dr. Moira Larsen, the discussion revisits how far laboratory sustainability has come since Dr. Gord ... Show More
41m 45s
Recommended Episodes
May 2025
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article in Nature. Disclosures can be foun ... Show More
21m 31s
May 2015
Biomarkers: Detecting Alzheimer's Early Enough to Treat it.
What are Biomarkers? And why are they useful in Alzheimer's Disease Research. 
21m 55s
May 2022
Liana G. Apostolova, MS, MD, FAAN - Accelerating Progress in the Treatment of Alzheimer’s Disease: How Can We Achieve Timely and Accurate Neuropathological Diagnosis and Precision Management of Mild Cognitive Impairment in Early Alzheimer’s Disease?
Go online to PeerView.com/JYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Alzheimer’s disease (AD) is a devastating, progressive neurodegenerative disorder affecting 10% of people over age 65 and increasing in global prev ... Show More
1h 44m
Sep 2023
Should You Get a Blood Test For Alzheimer's?
Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much—yet. Learn more about your ad choices. Visit megaphone.fm/adchoices 
10m 31s
Oct 2023
Blood Test for Alzheimer Disease
Dr. Rae Bacharach discusses the Neurology Today article, "Individuals Can Now Request a Blood Test for Alzheimer disease - Why Some Dementia Experts Are Wary". Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/10190/individuals_can_now_request_a_blood_test_ ... Show More
2m 37s
Aug 2023
Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease
<p>In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.<br /> <br /> <stron ... Show More
28m 48s
Feb 2024
Unveiling the Bigger Picture of Alzheimer's Disease: From New Disease Mechanisms to Biomarkers
<pre class="syntaxhighlighter-pre" data-syntaxhighlighter-params= "brush: xml; gutter: false; theme: Midnight" data-theme= "Midnight">Do you know all there is to know beyond amyloid and tau in Alzheimer's disease? Credit available for this activity expires: 02/15/25 Earn Credit ... Show More
33m 41s
Jun 2025
Advancing Radiology for Early Alzheimer's Detection - Sponsored by Eli Lilly and Company
<p>In this episode, Dr. Ashwin Parihar speaks with Dr. Petrice Cogswell about the radiologist's critical role in diagnosing Alzheimer's disease and how imaging advances are reshaping early detection. They also explore how innovation at scale, platform thinking, and operational al ... Show More
20m 44s
Nov 2023
Alzheimer’s Update, Part 2
This episode explores the current state of research on the multiple likely mechanisms of Alzheimer’s disease as well as promising treatments and diagnostics. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309944. 
54 m